Plasma theophylline concentrations in patients with chronic obstructive airways disease after administration of a new sustained release theophylline formulation.
作者信息
Taylor D R, Kinney C D, McDevitt D G
出版信息
Br J Clin Pharmacol. 1982 Apr;13(4):569-71. doi: 10.1111/j.1365-2125.1982.tb01423.x.
Abstract
摘要
相似文献
1
Plasma theophylline concentrations in patients with chronic obstructive airways disease after administration of a new sustained release theophylline formulation.慢性阻塞性气道疾病患者服用一种新的茶碱缓释制剂后的血浆茶碱浓度。
Br J Clin Pharmacol. 1982 Apr;13(4):569-71. doi: 10.1111/j.1365-2125.1982.tb01423.x.
2
Clinical use of controlled-release theophylline in chronic airways obstruction.控释茶碱在慢性气道阻塞中的临床应用。
J Int Med Res. 1987 Nov-Dec;15(6):391-6. doi: 10.1177/030006058701500610.
3
4
5
Circadian variation in plasma theophylline concentrations during maintenance therapy with a sustained-release preparation in patients with obstructive airways disease.阻塞性气道疾病患者在使用缓释制剂维持治疗期间血浆茶碱浓度的昼夜变化。
Br J Clin Pharmacol. 1984 Jul;18(1):27-30. doi: 10.1111/j.1365-2125.1984.tb05017.x.
6
Dose response relation to oral theophylline in severe chronic obstructive airways disease.重度慢性阻塞性气道疾病中口服氨茶碱的剂量反应关系。
BMJ. 1988 Dec 10;297(6662):1506-10. doi: 10.1136/bmj.297.6662.1506.
7
[Time-related distribution of delayed-action theophylline in the treatment of chronic obstructive bronchopneumopathies].
Presse Med. 1988 Feb 13;17(5):193-6.
8
Comparison of standard- and sustained-release theophylline tablets in patients with chronic obstructive pulmonary disease.慢性阻塞性肺疾病患者中标准释放型和缓释型茶碱片的比较。
Am J Hosp Pharm. 1979 May;36(5):613-7.
9
Treatment of chronic obstructive pulmonary disease with two sustained-release theophylline preparations.两种茶碱缓释制剂治疗慢性阻塞性肺疾病
J Int Med Res. 1987 Nov-Dec;15(6):352-60. doi: 10.1177/030006058701500604.
10
Use of serum theophylline level as a guide to optimum therapy in patients with chronic obstructive lung disease.使用血清茶碱水平指导慢性阻塞性肺疾病患者的最佳治疗。
J Clin Pharmacol. 1990 Apr;30(4):324-9. doi: 10.1002/j.1552-4604.1990.tb03601.x.
引用本文的文献
1
Prediction of optimum oral theophylline dose in patients with obstructive airways disease.阻塞性气道疾病患者最佳口服茶碱剂量的预测
Br J Clin Pharmacol. 1983 Jun;15(6):689-94. doi: 10.1111/j.1365-2125.1983.tb01551.x.
2
Is circadian variation in theophylline trough serum concentrations determined by time of dosing?茶碱血清谷浓度的昼夜变化是否由给药时间决定？
Br J Clin Pharmacol. 1984 Jun;17(6):777-9. doi: 10.1111/j.1365-2125.1984.tb02419.x.
本文引用的文献
1
Plasma theophylline concentrations following the oral administration of microcrystalline theophylline and a new sustained-release theophylline preparation to normal subjects.微晶型茶碱和一种新型茶碱缓释制剂口服给药后正常受试者的血浆茶碱浓度。
Eur J Clin Pharmacol. 1980 Oct;18(4):351-4. doi: 10.1007/BF00561394.
2
Pharmacokinetics of theophylline. Application to adjustment of the clinical dose of aminophylline.茶碱的药代动力学。在氨茶碱临床剂量调整中的应用。
Clin Pharmacol Ther. 1972 May-Jun;13(3):349-60. doi: 10.1002/cpt1972133349.
3
Rational intravenous doses of theophylline.氨茶碱的合理静脉给药剂量。
N Engl J Med. 1973 Sep 20;289(12):600-3. doi: 10.1056/NEJM197309202891202.
4
Dosage of theophylline in bronchial asthma.支气管哮喘中茶碱的剂量
N Engl J Med. 1975 Jun 5;292(23):1218-22. doi: 10.1056/NEJM197506052922305.
5
Measurement of theophylline in plasma by high performance liquid chromatography.采用高效液相色谱法测定血浆中的茶碱。
Br J Clin Pharmacol. 1976 Oct;3(5):947-8. doi: 10.1111/j.1365-2125.1976.tb00657.x.
6
Clinical pharmacokinetics of theophylline.茶碱的临床药代动力学
Clin Pharmacokinet. 1978 Jul-Aug;3(4):267-93. doi: 10.2165/00003088-197803040-00002.
Zotero 插件